Otsuka Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Co., Ltd.

Chiyoda City, Tokyo, Japan

Neupro Patch

Neupro Patch

Neupro Patch

Neupro Patch is the world's only once-daily transdermal dopamine agonist. In 2002 Otsuka obtained development and marketing rights in Japan from the Belgian company UCB. In Japan, it has been marketed since 2013.

Product Enquiry

SSL Secure Connection